tiprankstipranks
Trending News
More News >
Cyclerion Therapeutics,Inc. (CYCN)
:CYCN
US Market
Advertisement

Cyclerion Therapeutics (CYCN) Price & Analysis

Compare
243 Followers

CYCN Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

21.50%1.20%8.76%67.40%
21.50% Insiders
8.76% Other Institutional Investors
67.40% Public Companies and
Individual Investors

CYCN FAQ

What was Cyclerion Therapeutics,Inc.’s price range in the past 12 months?
Cyclerion Therapeutics,Inc. lowest stock price was $1.27 and its highest was $9.47 in the past 12 months.
    What is Cyclerion Therapeutics,Inc.’s market cap?
    Cyclerion Therapeutics,Inc.’s market cap is $9.18M.
      When is Cyclerion Therapeutics,Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Cyclerion Therapeutics,Inc.’s earnings last quarter?
      Currently, no data Available
      Is Cyclerion Therapeutics,Inc. overvalued?
      According to Wall Street analysts Cyclerion Therapeutics,Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Cyclerion Therapeutics,Inc. pay dividends?
        Cyclerion Therapeutics,Inc. does not currently pay dividends.
        What is Cyclerion Therapeutics,Inc.’s EPS estimate?
        Cyclerion Therapeutics,Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Cyclerion Therapeutics,Inc. have?
        Cyclerion Therapeutics,Inc. has 3,210,094 shares outstanding.
          What happened to Cyclerion Therapeutics,Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Cyclerion Therapeutics,Inc.?
          Currently, no hedge funds are holding shares in CYCN

          Company Description

          Cyclerion Therapeutics,Inc.

          Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative treatments for serious diseases. The company operates within the biotechnology sector and primarily engages in the research and development of therapeutics aimed at central nervous system (CNS) disorders. Cyclerion leverages its expertise in soluble guanylate cyclase (sGC) stimulators to create novel therapeutics that address high unmet medical needs.
          Similar Stocks
          Company
          Price & Change
          Follow
          Carisma Therapeutics
          Aprea Therapeutics
          Evaxion Biotech
          HCW Biologics
          Turnstone Biologics Corp.
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis